newsfilter
← Latest News
Business Wire·

Athersys Licenses its Animal Health Assets to Ardent Animal Health

Athersys, Inc. (NASDAQ:ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, and Multipotent Adult Progenitor Cell (MAPC®) technology for